Biopharma News

Jan 30, 2017
Despite the threat of competition, both from biosimilars to Humira and new therapies that work through other mechanisms of action, AbbVie says Humira is still number one.
Jan 27, 2017
By BioPharm International Editors
ADMA will acquire BPC’s plasma-based fractionation and purification plant in Boca Raton, FL and plans to resolve issues at the facility noted in an FDA warning letter.
Jan 26, 2017
By BioPharm International Editors
After a positive Phase II trial, the company said its C. difficile vaccine candidate will advance to Phase III trials during the first half of 2017.
Jan 26, 2017
By BioPharm International Editors
The companies will split Actelion’s drug discovery and early-stage clinical development assets into a new Swiss biopharmaceutical company.
Jan 26, 2017
The company will gain the rights to a mutein that is believed to help maintain immune system homeostasis.
Jan 25, 2017
Researchers from Cellectis investigate how external signals in the tumor microenvironment could control the cell-surface expression and specificity of engineered CARs.
Jan 24, 2017
Merck will pay a one-time fee of $625 million and additional royalties to BMS and Ono Pharmaceutical to settle the patent infringement case related to Keytruda.
Jan 20, 2017
The company will begin trials with its CBD chewing gum, CanChew Plus, for the treatment of irritable bowel syndrome.
Jan 19, 2017
By BioPharm International Editors
Luke Miels will replace Abbas Hussain as president of GSK’s Global Pharmaceutical division later this year.
Jan 19, 2017
Researchers were not able to replicate all of the findings in five highly-cited cancer biology papers.
native1_300x100
lorem ipsum